期刊文献+

肝动脉化疗栓塞术前、后静脉应用止吐药物的临床研究 被引量:14

Clinical Study on the Effects of Intravenous Antiemetics before or after Transcatheter Arterial Chemoembolization
下载PDF
导出
摘要 目的 研究肝动脉化疗栓塞术前、后静脉应用止吐药物对术后消化道化疗反应的影响,为临床护士执行医嘱提供依据。方法 运用观察研究法,对106例接受肝动脉化疗栓塞治疗的患者进行随机分组,分别于肝动脉化疗栓塞术前、后30~60min内静脉应用止吐药物,分析比较术后消化道化疗反应程度及药物疗效。结果 两组患者术后3d内的消化道化疗反应程度无显著性差异(P>0.05);两组患者静脉应用同种及同剂量止吐药的有效性比较,仍无显著性差异(P>0.05)。结论 肝动脉化疗栓塞术前、后30~60min内静脉应用止吐药疗效无明显差异,但术后应用止吐药可防止各种不可控因素使患者不能按计划接受治疗造成的药物浪费和思想顾忌,且减少术前静脉穿刺给患者带来的痛苦。 Objective To compare the effects of intravenous antiemetics on digestive chemotherapy reactions before and after TACE in an attempt to establish guidelines for nurses in implementing medical orders. Methods 106 patients with hepatocellular carcinoma who underwent TACE were divided into two groups randomly. Antiemetics were administered intravenously 30 -60 minutes before or after TACE, and the degrees of digestive chemotherapy reactions and curative effects were compared and analyzed. Results There was no significant difference in the degree of digestive reactions at 3 days of post-operation between the two groups ( P >0.05). The antiemetic effects were not significantly different between the two groups with reference to the same drug at the same dose ( P >0. 05). Conclusion There was no significant difference in the clinical effect of intravenous use of the antiemetics 30 - 60 minutes before or after TACE, but use of antiemetics after TACE can avoid wasting drugs because of patients' refusal to use the drug due to uncontrolled factors and free patients of pain from venipuncture before TACE.
出处 《解放军护理杂志》 2003年第7期28-30,共3页 Nursing Journal of Chinese People's Liberation Army
关键词 肝动脉化疗栓塞术 术前 术后 止吐药物 恶心 呕吐 原发性肝癌 transcatheter arterial chemoembolization (TACE) chemotherapy reaction antiemetics
  • 相关文献

参考文献3

二级参考文献20

  • 1汤毅,胡景钤,罗鹏飞,陈晓明,周泽健,符力.肝癌经肝动脉化疗术后上消化道出血的原因与预防[J].临床肝胆病杂志,1996,12(1):26-28. 被引量:5
  • 2陈灏珠.实用内科学[M](第10版)[M].北京:人民卫生出版社,1997.835-838.
  • 3Tepler I, Elias L, Smith JW, et al. A randomized placebo-controlled trial of recombinsnt human interliukin-11 in canear patients with severe thrombocytopenia due to chemotherapy[J]. Blood, 1996, 87(9): 3607-3614.
  • 4Isaaes C, Robert NJ, Bailey FA, et al. Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin[J]. J Clin Oncol, 1997, 15(11): 3368-3377.
  • 5Perez EA, Lembersky B, Kaywin P, et al. Intravenous(IV) granisetron vs ondansetron in the prevention of cyclophosphamide-doxorubicin-induced emesis in breast cancer patients: a double blind crossover study[J]. Proc Am Soc Clin Oncol, 1996, 15: 543.
  • 6Perez EA, Hesketh P, Sandbach J, et al. Comparison of single dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetngenic chemotherapy: a multicenter, double-blind, randimized parallel study[J]. J Clin Oncol, 1998, 16(2): 754-760.
  • 7Navari R, Gandara D,Hesketh P,et al. Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin induced emesis[J]. J Clin Oncol, 1995, 13(5): 1242-1248.
  • 8Gralla RJ, Navari RM, Hesketh PJ, et al. Single-dose oral granisetron, has equivalent antiernetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based ehernotherapy[J]. J Clin Oncol, 1998, 16(4): 1568-1573.
  • 9Anonymous. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy[J]. N Engl J Med, 2000, 342(21): 1554-1559.
  • 10Crawford J, Ozer H, Stoller R, et al. Reduction by granuloeyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer (r-metHuC- CSF) [J]. N Engl J Med, 1991,325(3) : 164-170.

共引文献27

同被引文献78

引证文献14

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部